Xiao et al. demonstrated that exogenous over-expression of TRIM2 significantly inhibited the proliferation, migration and invasion of RCC cells, suggesting that the positive regulation of TRIM2 might be a novel therapeutic target for ccRCC [30]. Here, TRIM2 is linked to nonpapillary renal cell carcinoma.